We performed this study in an attempt to reconcile the differences with respect to Ga-67 uptake as a function of tumor grade and type in the literature, as well as to determine the sensitivity of (TI)-T-201 uptake in both Hodgkin's and non-Hodgkin's lymphoma, Methods: Thirty-six (9 with low-grade lymphoma, 11 with intermediate-grade lymphoma, 4 with high-grade lymphoma and 12 with Hodgkin's lymphoma) patients underwent both Ga-67 and (TI)-T-201 scintigraphy, Biopsies were done on all patients. A semiquantitative rating system was used to make statistical comparisons for thallium versus gallium in all lymphoma subgroups, as well as comparisons of thallium and gallium to themselves in all subgroups. Results: Patient sensitivity was only 56% and site sensitivity was 32% in patients with low-grade lymphoma. Conversely, (TI)-T-201 sensitivity was 100%, respectively, for patients and sites. The difference between (TI)-T-201 and Ga-67 sensitivity in patients with low-grade lymphoma on a site basis was statistically significant. When compared to itself in lymphoma subgroups, (TI)-T-201 was found to be statistically more avid for low-grade lymphoma than for intermediate, high or Hodgkin's lymphoma. Gallium-67 sensitivity for low-grade lymphoma was significantly less than for Hodgkin's and intermediate grade lymphomas. No significant differences were found when (TI)-T-201 and Ga-67 were compared in the intermediate, high or Hodgkin's lymphoma groups. Conclusion: Thallium-201 demonstrates significantly greater tumor avidity in the low-grade lymphoma group compared to Ga-67 citrate. Gallium-67-citrate appears relatively nonavid for low-grade lymphoma compared to (TI)-T-201 and is statistically inferior in detecting low-grade lymphoma in comparison to its ability to detect intermediate or high-grade lymphomas. Gallium-67-citrate should not be considered dependable in evaluating patients with low-grade lymphoma. Neither (TI)-T-201 or Ga-67 is dependable in the evaluation of low-grade lymphoma within the abdomen, since gallium avidity for low-grade lymphoma is low and gastrointestinal excretion of (TI)-T-201 is poorly controlled.